Promedior
Malvern, US · 4 known investors
Biotech
Founders & leadership
ML
Mark LupherNamed on SEC filing
JW
James W. Broderick, M.D.Named on SEC filing
GM
Geert-Jan MulderNamed on SEC filing
JF
John FriedmanNamed on SEC filing
DC
Dominick C. ColangeloNamed on SEC filing
PD
Paul D. Goldenheim, M.D.Named on SEC filing
HR
Harold R. WernerNamed on SEC filing
AN
Amir NashatNamed on SEC filing
HA
Hanns A. PielenzNamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$21.8M disclosed across 1 round · 2012
▶$21.8MraisedMar 2012 · 11 investors · PharmaceuticalsRule 506(b)
▶$21.8MraisedMar 2012 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark LupherExecutive Officer
- James W. Broderick, M.D.Director
- Geert-Jan MulderDirector
- John FriedmanDirector
- Dominick C. ColangeloExecutive Officer, Director
- Paul D. Goldenheim, M.D.Director
- Harold R. WernerDirector
- Amir NashatDirector
- Hanns A. PielenzDirector
- Offering amount
- $28M
- Amount sold
- $21.8M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Promedior's investors?
- Promedior's investors include Easton Capital, Sofinnova Ventures, Easton Capital Investment Group, Forbion.
- How much funding has Promedior raised?
- Promedior has disclosed $21.8M raised across 1 round.
- Where is Promedior headquartered?
- Promedior is headquartered in Malvern, US.